期刊
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
卷 40, 期 7, 页码 3129-3131出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/07391102.2020.1845801
关键词
Camelid; heavy-chain antibody; SARS-CoV-2; therapeutic; diagnostic
COVID-19 is a highly contagious disease caused by SARS-CoV-2, with rapid global spread and high fatality rates. Currently, there are no available vaccines or specific therapies. This paper highlights the potential utility of nanobodies for therapeutic and diagnostic interventions.
Coronavirus disease 2019 (COVID-19) is a highly contagious disease caused by severe acute respiratory coronavirus 2 (SARS-CoV-2). This virus is capable of human-to-human transmission, and is spreading rapidly round the globe, with markedly high fatality rates. Unfortunately, there are neither vaccines nor specific therapies available to combat it, and the developments of such approaches depend on pursuing multiple avenues in biomedical science. Accordingly, in this paper we highlight one such avenue-nanobodies-for potential utility in therapeutic and diagnostic interventions to combat COVID-19. Communicated by Ramaswamy H. Sarma
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据